Avadel Pharmaceuticals Reports Second Quarter 2017 Results
Aug 08, 2017 11:30 am UTC| Business
Total Revenues Increased 19% on a Year-Over-Year Basis to $46.3 Million Strong Year-to-Date Operating Cash Flow of $33.5 Million DUBLIN, Ireland, Aug. 08, 2017 -- Avadel Pharmaceuticals plc (NASDAQ:AVDL) today...
Aug 08, 2017 11:30 am UTC| Business
– 1002-038 Study Meets Primary Endpoint With a Robust 64% LDL-C Lowering Efficacy –– Clinically Relevant 48% hsCRP Reduction –– The Combination Therapy Was Observed to be Safe and Well-Tolerated –– Conference Call and...
Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab
Aug 08, 2017 11:30 am UTC| Business
- Dermira plans to develop and commercialize lebrikizumab, a monoclonal antibody targeting IL-13, for moderate-to-severe atopic dermatitis - Initiation of a Phase 2b clinical study is expected in the first quarter of...
Neuralstem Reports Second Quarter 2017 Fiscal Results and Provides Clinical and Business Update
Aug 08, 2017 11:30 am UTC| Business
GERMANTOWN, Md., Aug. 08, 2017 -- Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, reported its financial...
Aug 08, 2017 11:30 am UTC| Business
Study Confirms Intranasal Abuse of Hydrocodone/Acetaminophen by Adolescents Adults may be a Significant Public Health Issue CORALVILLE, Iowa, Aug. 08, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty...
Aug 08, 2017 11:30 am UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, Aug. 08, 2017 -- Altisource Residential Corporation (“RESI” or the “Company”) (NYSE:RESI) today announced financial and operating results for the second quarter of 2017. Second...
Aug 08, 2017 11:30 am UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, Aug. 08, 2017 -- Altisource Asset Management Corporation (“AAMC” or the “Company”) (NYSE MKT:AAMC) today announced financial and operating results for the second quarter of 2017. ...